MX2020012292A - Compuestos para el tratamiento de cáncer de pancreas. - Google Patents

Compuestos para el tratamiento de cáncer de pancreas.

Info

Publication number
MX2020012292A
MX2020012292A MX2020012292A MX2020012292A MX2020012292A MX 2020012292 A MX2020012292 A MX 2020012292A MX 2020012292 A MX2020012292 A MX 2020012292A MX 2020012292 A MX2020012292 A MX 2020012292A MX 2020012292 A MX2020012292 A MX 2020012292A
Authority
MX
Mexico
Prior art keywords
pancreatic cancer
compounds
treatment
formula
therapeutically effective
Prior art date
Application number
MX2020012292A
Other languages
English (en)
Spanish (es)
Inventor
Wei Li
Miller Duane D
Wang Qinghui
Subhash Chauhan
Vivek Kumar Kashyap
Original Assignee
Univ Tennessee Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tennessee Res Found filed Critical Univ Tennessee Res Found
Publication of MX2020012292A publication Critical patent/MX2020012292A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MX2020012292A 2018-05-15 2019-05-15 Compuestos para el tratamiento de cáncer de pancreas. MX2020012292A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862671833P 2018-05-15 2018-05-15
PCT/US2019/032476 WO2019222392A1 (en) 2018-05-15 2019-05-15 Compounds for treatment of pancreatic cancer

Publications (1)

Publication Number Publication Date
MX2020012292A true MX2020012292A (es) 2021-03-29

Family

ID=68541005

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020012292A MX2020012292A (es) 2018-05-15 2019-05-15 Compuestos para el tratamiento de cáncer de pancreas.

Country Status (9)

Country Link
US (1) US20190374512A1 (cg-RX-API-DMAC7.html)
EP (1) EP3793548A4 (cg-RX-API-DMAC7.html)
JP (1) JP2021523915A (cg-RX-API-DMAC7.html)
KR (1) KR20210021982A (cg-RX-API-DMAC7.html)
CN (1) CN112437664A (cg-RX-API-DMAC7.html)
AU (1) AU2019270091A1 (cg-RX-API-DMAC7.html)
CA (1) CA3099922A1 (cg-RX-API-DMAC7.html)
MX (1) MX2020012292A (cg-RX-API-DMAC7.html)
WO (1) WO2019222392A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL293661B2 (en) * 2020-04-03 2025-11-01 Veru Inc Sabizabulin for treating coronavirus infection
MX2023011719A (es) * 2021-04-05 2023-11-09 Veru Inc Métodos de tratamiento de la inflamación.
IL316387A (en) * 2022-04-28 2024-12-01 Veru Inc Polymorphs of [2-(1H-INDOL-3-YL)-1H-IMIDAZOL-4-YL](3,4,5-TRIMETHOXYPHENYL)methanone and its salts

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8822513B2 (en) * 2010-03-01 2014-09-02 Gtx, Inc. Compounds for treatment of cancer
US9447049B2 (en) * 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
UA105005C2 (uk) * 2008-06-16 2014-04-10 Юніверсіті Оф Теннессі Рісерч Фаундейшн Сполуки для лікування раку
US9029408B2 (en) * 2008-06-16 2015-05-12 Gtx, Inc. Compounds for treatment of cancer
CA2791738C (en) * 2010-03-01 2020-06-09 Gtx, Inc. Aryl imidazolyl compounds for the treatment of cancer
MX336761B (es) * 2010-08-24 2016-01-29 Univ Tennessee Res Foundation Compuestos para el tratamiento de cancer.
CN105163584B (zh) * 2013-03-05 2019-06-04 田纳西大学研究基金会 用于治疗癌症的化合物

Also Published As

Publication number Publication date
JP2021523915A (ja) 2021-09-09
EP3793548A4 (en) 2022-03-09
KR20210021982A (ko) 2021-03-02
AU2019270091A1 (en) 2020-12-24
US20190374512A1 (en) 2019-12-12
CA3099922A1 (en) 2019-11-21
CN112437664A (zh) 2021-03-02
EP3793548A1 (en) 2021-03-24
WO2019222392A1 (en) 2019-11-21

Similar Documents

Publication Publication Date Title
MX2023000410A (es) Analogos de rapamicina como inhibidores de mtor.
ES3065771T3 (en) Substituted oxoisoindoline compounds for the treatment of cancer
ZA202003176B (en) Compounds useful as kinase inhibitors
MX2023000025A (es) Inhibidores de la quinasa progenitora hematopoyética 1 y usos de estos.
ZA201906111B (en) Cyclic di-nucleotides compounds for the treatment of cancer
MX2020011234A (es) Moduladores de receptor similar al dominio de oligomerizacion de union a nucleotidos que contiene dominio de pirina 3 (nlrp3).
PH12018502102A1 (en) Pyrrolotriazine compounds as tam inhibitors
MX2022005827A (es) Derivados de pirazol como inhibidores de malt1.
PH12018500587A1 (en) Pyrazolopyrimidine derivatives as btk inhibitors for the treatment of cancer
ZA202001717B (en) Compounds, salts thereof and methods for treatment of diseases
MX2020012291A (es) Compuestos para el tratamiento de cancer de mama triple negativo y cancer de ovario.
MX2017012729A (es) Inhibidores de indolamina 2,3-dioxigenasa (ido) para el tratamiento de cancer.
PH12018500268A1 (en) 2-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyridins as bace1 inhibitors
PH12020551390A1 (en) AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS
NZ759764A (en) Glucuronide prodrugs of janus kinase inhibitors
NZ761519A (en) Nlrp3 modulators
PH12021553132A1 (en) Methods of using rad51 inhibitors for treatment of pancreatic cancer
PH12022550491A1 (en) Perk inhibiting pyrrolopyrimidine compounds
EA202090414A1 (ru) Соединения и их применение
EA201792287A1 (ru) Способы лечения рака
PH12022550497A1 (en) Perk inhibiting compounds
MX2020012281A (es) Composiciones que comprenden compuestos de bisfluoroalquil-1,4-ben zodiacepinona y metodos de uso de las mismas.
EA201690763A1 (ru) Лечение рака поджелудочной железы
IL289201A (en) Compounds for the treatment of cancer
EP3793548A4 (en) COMPOUNDS FOR TREATMENT OF PANCREA CANCER